Remove Business Remove DEA Remove Programs
article thumbnail

What Could Rescheduling Mean for Medical Cannabis Patients?

Canna Care Docs

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. Understanding current drug scheduling for cannabis The DEA classifies drugs, substances, and certain chemicals used to make drugs into five distinct categories or “schedules.”

Patients 111
article thumbnail

Intoxicating Hemp Swindle

Project CBD

What’s more, synthesized Delta-9 THC is present in many of these products, despite being prohibited in both California’s cannabis and hemp programs. In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis.

Hemp 232
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Congressional Committee to Hold Marijuana Legislative Hearing This Wednesday

NORML

Now more than ever, congressional action is required to end the failed criminalization of marijuana and amend federal law to ensure that state-legal cannabis programs can operate as intended. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Witnesses will be: Matthew J. Volkow, M.D.,

article thumbnail

House Energy and Commerce Subcommittee Considers ‘Cannabis Policies for the New Decade’

NORML

. “At a time when nearly 70 percent of all Americans want to end our failed federal policy of blanket cannabis criminalization, it is unfortunate to see so many participants at this hearing advocating largely for business as usual,” said NORML Executive Director Erik Altieri. Witnesses at today’s hearing were: Matthew J.

Policy 199
article thumbnail

DEA Finally Agrees to Expand Marijuana Research Amid Pressure from Lawsuit

WeedAdvisor

Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Given the DEA’s stonewalling, forcing their hand is a notable achievement. Dozens of Applications”. .

DEA 61
article thumbnail

Press Release: Cybin Granted DEA Schedule I Manufacturing License

Cannabis Law Report

Cybin Granted DEA Schedule I Manufacturing License. Drug Enforcement Agency (“DEA”). The DEA license is a federal requirement for any investigators who intend to study, produce, analyze or otherwise work with Schedule I controlled substances. The DEA license is for the Company’s research lab in the Boston area.

DEA 52
article thumbnail

The Week in Weed: September 1, 2023

The Blunt Truth

SOUTH DAKOTA Has South Dakota’s medical cannabis program been too successful? Some lawmakers, concerned that the 12,000 cards issued by the state’s MMJ program is nearly double original projections, are calling for closer monitoring of the process. Proposed rules for the program could be introduced in the legislature later this year.

DEA 98